Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study.
Atherosclerosis
Autoimmune thyroiditis
Coeliac disease
Endothelial function
Reactive hyperemia flow mediated dilation
Type 1 diabetes
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
23 Jul 2022
23 Jul 2022
Historique:
received:
23
04
2022
accepted:
14
07
2022
entrez:
23
7
2022
pubmed:
24
7
2022
medline:
24
7
2022
Statut:
epublish
Résumé
Type 1 diabetes (T1D) is frequently associated with autoimmune thyroiditis (AT) and coeliac disease (CD). Whether the coexistence of multiple autoimmune diseases increases cardiovascular risk is uncertain. We evaluated the effects of AT and CD on arterial wall thickening and endothelial function in patients with T1D. This observational study analyzed data from T1D patients regularly followed by the Diabetes Care Centre. Clinical and biochemical characteristics and micro and macrovascular complications were collected from the electronic medical records. All subjects performed Echo-Doppler to evaluate Intima-Media Thickness (IMT) of the common carotid artery (CCA) and endothelial function by the flow-mediated dilation (FMD) technique. The statistical analyses were performed by SPSS for Macintosh. Comparison between means was performed using the t-test for unpaired data and the Mann-Whitney U test. The ANalysis Of VAriance and the Tukey posthoc test were applied to compare patients with and without other autoimmune diseases, and control subjects. The p-value for statistical significance was set at p < 0.05. A total of 110 patients were enrolled. Among these, 69 had T1D and 41 T1D and AT and or CD, of whom 33 AT, 7 CD, and 1 both AT and CD. The mean age was 35 years, mean HbA1c was 7.6%, and mean diabetes duration 18 years. The IMT of the CCA was not significantly different between T1D patients with and without concomitant autoimmune diseases (with AT and CD: right CCA 603 ± 186 µ, left 635 ± 175 µ; without AT and CD: right CCA 611 ± 176 µ, left CCA 631 ± 200 µ). FMD was also comparable between T1D groups, with AT and CD 7.9 ± 4.2%; without AT and CD 8.8 ± 4.4%. Patients with T1D and concomitant AT and or CD show no worse morphological or functional vascular damage, evaluated by CCA IMT and brachial artery flow-mediated dilation, than patients with T1D alone.
Sections du résumé
BACKGROUND
BACKGROUND
Type 1 diabetes (T1D) is frequently associated with autoimmune thyroiditis (AT) and coeliac disease (CD). Whether the coexistence of multiple autoimmune diseases increases cardiovascular risk is uncertain. We evaluated the effects of AT and CD on arterial wall thickening and endothelial function in patients with T1D.
METHODS
METHODS
This observational study analyzed data from T1D patients regularly followed by the Diabetes Care Centre. Clinical and biochemical characteristics and micro and macrovascular complications were collected from the electronic medical records. All subjects performed Echo-Doppler to evaluate Intima-Media Thickness (IMT) of the common carotid artery (CCA) and endothelial function by the flow-mediated dilation (FMD) technique. The statistical analyses were performed by SPSS for Macintosh. Comparison between means was performed using the t-test for unpaired data and the Mann-Whitney U test. The ANalysis Of VAriance and the Tukey posthoc test were applied to compare patients with and without other autoimmune diseases, and control subjects. The p-value for statistical significance was set at p < 0.05.
RESULTS
RESULTS
A total of 110 patients were enrolled. Among these, 69 had T1D and 41 T1D and AT and or CD, of whom 33 AT, 7 CD, and 1 both AT and CD. The mean age was 35 years, mean HbA1c was 7.6%, and mean diabetes duration 18 years. The IMT of the CCA was not significantly different between T1D patients with and without concomitant autoimmune diseases (with AT and CD: right CCA 603 ± 186 µ, left 635 ± 175 µ; without AT and CD: right CCA 611 ± 176 µ, left CCA 631 ± 200 µ). FMD was also comparable between T1D groups, with AT and CD 7.9 ± 4.2%; without AT and CD 8.8 ± 4.4%.
CONCLUSION
CONCLUSIONS
Patients with T1D and concomitant AT and or CD show no worse morphological or functional vascular damage, evaluated by CCA IMT and brachial artery flow-mediated dilation, than patients with T1D alone.
Identifiants
pubmed: 35870966
doi: 10.1186/s13098-022-00877-y
pii: 10.1186/s13098-022-00877-y
pmc: PMC9308025
doi:
Types de publication
Journal Article
Langues
eng
Pagination
103Informations de copyright
© 2022. The Author(s).
Références
Endocr J. 2011;58(5):349-54
pubmed: 21490407
Acta Diabetol. 2013 Aug;50(4):497-503
pubmed: 21691748
Physiol Rep. 2020 Aug;8(15):e14518
pubmed: 32748565
Diabetes Care. 2003 May;26(5):1589-96
pubmed: 12716823
Curr Rheumatol Rep. 2009 Feb;11(1):61-9
pubmed: 19171113
Exp Clin Endocrinol Diabetes. 2014 Apr;122(4):208-14
pubmed: 24771008
Pediatr Endocrinol Diabetes Metab. 2016;22(3):
pubmed: 28633159
Autoimmun Rev. 2016 Jul;15(7):644-8
pubmed: 26903475
BMJ. 2018 Sep 4;362:k1497
pubmed: 30181166
J Endocrinol Invest. 2005 Jul-Aug;28(7):616-22
pubmed: 16218044
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1980-8
pubmed: 27386941
BMC Cardiovasc Disord. 2010 May 28;10:22
pubmed: 20509904
Gastroenterology. 2021 Jan;160(1):63-75
pubmed: 32950520
Endocrinol Metab Clin North Am. 2020 Mar;49(1):1-18
pubmed: 31980111
Atherosclerosis. 2011 Aug;217(2):531-5
pubmed: 21601206
Microvasc Res. 2019 May;123:68-73
pubmed: 30611746
J Womens Health (Larchmt). 2020 Apr;29(4):511-519
pubmed: 32320330
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
J Diabetes. 2019 Apr;11(4):273-279
pubmed: 30226016
Front Endocrinol (Lausanne). 2020 Jul 24;11:431
pubmed: 32793113
Diab Vasc Dis Res. 2013 Nov;10(6):472-82
pubmed: 24002671
Aliment Pharmacol Ther. 2013 Jul;38(2):162-9
pubmed: 23730933
Diabetes Care. 2011 Oct;34(10):2158-63
pubmed: 21911773